Insider filing · FENC
Fennec Pharmaceuticals Inc.
FENC · Healthcare · 9 filings in 24 months
ticker →
Southpoint Capital Advisors LLC sold $636K of Fennec Pharmaceuticals (FENC)
Executed Oct 7 2025, disclosed Oct 9 2025, 2 days later.
Value, as filed
$636K
67,114 sh across 3 lots
Executed
Oct 7 2025
the trade date, as filed
Disclosed
Oct 9 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SL
Southpoint Capital Advisors LLC
10% owner
profile →
Southpoint Capital Advisors LLC (10% owner) filed 2 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 2 sales), most often in Fennec Pharmaceuticals Inc. (FENC). The largest single filing was $636K of FENC (67,114 sh across 3 lots, as filed), executed Oct 7 2025.
The name
FENCHealthcare · Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Southpoint Capital Advisors LLC in FENC
FENCSALE
Fennec Pharmaceuticals Inc.
$170K19,341 sh × $8.79
Exec Nov 18 2025
Filed Nov 20 2025 · 5:30 PM ET